首页 | 本学科首页   官方微博 | 高级检索  
检索        

化疗对乳腺癌患者外周血CD4~+CD25~+CD127~-调节性T细胞的影响
引用本文:樊静,任红,张凤春,景晓春,李建柱,康文喜.化疗对乳腺癌患者外周血CD4~+CD25~+CD127~-调节性T细胞的影响[J].中国预防医学杂志,2011(10):881-883.
作者姓名:樊静  任红  张凤春  景晓春  李建柱  康文喜
作者单位:秦皇岛市肿瘤医院;
摘    要:目的观察化疗对乳腺癌患者外周血免疫指标的变化并探讨其影响。方法采用流式细胞术分析129例乳腺癌患者化疗前后CD4+CD25+CD127-调节性T细胞占CD4+T细胞的比率及T淋巴细胞亚群CD3、CD4、CD8;B淋巴细胞CD19;NK细胞(CD16+CD56)和CD4/CD8比值的动态变化。结果化疗后的乳腺癌患者CD4+CD25+CD127-调节性T细胞占CD4+细胞比率较化疗前降低,T淋巴细胞亚群中CD3、CD4、CD4/CD8增高,CD8、NK和CD19降低;乳腺癌患者外周血调节性T细胞的数量与临床分期和组织分化程度相关。结论乳腺癌患者化疗后调节性T细胞的数量降低,免疫调节抑制功能下降,免疫功能得到提高,但体液免疫及NK功能未见提高。

关 键 词:乳腺癌  化疗  CD4+CD25+CD127-调节性T细胞  流式细胞术

Impact of chemotherapy on peripheral blood CD4~+CD25~+CD127~- regulatory T cells in breast cancer patients
FAN Jing,REN Hong,ZHANG Feng-chun,JING Xiao-chun,LI Jian-zhu,KANG Wen-xi.Clinical Laboratory,Qinhuangdao Cancer Hospital,Qinhuangdao,Hebei ,China.Impact of chemotherapy on peripheral blood CD4~+CD25~+CD127~- regulatory T cells in breast cancer patients[J].China Preventive Medicine,2011(10):881-883.
Authors:FAN Jing  REN Hong  ZHANG Feng-chun  JING Xiao-chun  LI Jian-zhu  KANG Wen-xiClinical Laboratory  Qinhuangdao Cancer Hospital  Qinhuangdao  Hebei  China
Institution:FAN Jing,REN Hong,ZHANG Feng-chun,JING Xiao-chun,LI Jian-zhu,KANG Wen-xi.Clinical Laboratory,Qinhuangdao Cancer Hospital,Qinhuangdao,Hebei 066004,China
Abstract:Objective To investigate the impact of chemotherapy on CD4+CD25+CD127-T regulatory cells in breast cancer patients.Methods We analyzed the peripheral blood cells,including NK,B lymphocyte CD19,and the T lymphocyte subgroups of CD3,CD4,CD8 and CD4+CD25+CD127-regulatory T cells in l29 patients with cancer before and after chemotherapy by flow cytometry.The ratio of CD4/CD8 was dynamically observed during the treatment.Results The cell counts of CD4,CD3 and the ratio of CD4/CD8 increased while the cell counts ...
Keywords:Breast cancer  CD4 CD25 CD127  regulatory T cell  Flow cytometry  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号